SpectraCure AB (SPEC) — Capital Reinvestment Ratio
Latest as of June 2025:
1.35x
SpectraCure AB (SPEC) has a Capital Reinvestment Ratio of 1.35x as of June 2025, meaning it reinvests 1% of its operating cash flow (Skr3.58 Million) in capital expenditures (Skr4.83 Million). See SpectraCure AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.35x
Capex / Operating Cash Flow
Operating Cash Flow
Skr3.58 Million
SEK
Capital Expenditures
Skr4.83 Million
SEK
Data as of
Jun 2025
Most recent filing
SpectraCure AB Capital Reinvestment Ratio (2017–2017)
This chart tracks SpectraCure AB's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for SpectraCure AB (2017–2017)
Year-by-year Capital Reinvestment Ratio for SpectraCure AB from 2017 to 2017. For live market cap and broader valuation context, see SpectraCure AB market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.67x | Skr6.33 Million | Skr4.27 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow